Rohit Bose, MD, PhD

Rohit Bose, MD, PhD

Rohit Bose, MD, PhD

Assistant Professor of Anatomy and Urology

Education

Instructor, 2018 - Dept. of Medicine, Genitourinary Service, Memorial Sloan Kettering Cancer Center
Fellowship, 2016 - Advanced Oncology, Memorial Sloan Kettering Cancer Center
Fellowship, Medical Research Track, 2014 - Medical Oncology, Memorial Sloan Kettering Cancer Center
Residency, Medical Research Track, 2010 - Internal Medicine, Weill Cornell Medicine
MD/PhD, 2008 - Medicine & Molecular Genetics, University of Toronto

Biography

I'm a physician-scientist who sees prostate cancer patients, and runs a prostate cancer-focused research lab. Our focus is in understanding hormone-related tumor evolution and dynamics. Understanding how tumors shift their dependencies and identity during therapy is critical to improving patients' clinical care.

Research Interests

September 15, 2023 - August 31, 2028 - Simulating Ancestrally Unbiased Tumor Evolution to Interrogate Drug Resistance , Principal Investigator . Sponsor: NIH Common Fund, Sponsor Award ID: DP2CA290244

July 1, 2022 - June 30, 2026 - Interrogating tumor sub-clonality and shifting dependencies to reduce castration therapy , . Sponsor: American Cancer Society, Sponsor Award ID: RSG-22-021-01-CDP

June 20, 2023 - June 19, 2026 - Profiling and Eliminating Tumor Subclones Destined for Resistance , . Sponsor: DOD Prostate Cancer Program, Sponsor Award ID: P0563731

September 15, 2018 - August 31, 2023 - Investigating How a Balance of Negative and Positive ETS Factors Controls Prostate Oncogenesis , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K08CA226348

September 15, 2023 - August 31, 2028 - Simulating Ancestrally Unbiased Tumor Evolution to Interrogate Drug Resistance , Principal Investigator . Sponsor: NIH Common Fund, Sponsor Award ID: DP2CA290244
July 1, 2022 - June 30, 2026 - Interrogating tumor sub-clonality and shifting dependencies to reduce castration therapy , . Sponsor: American Cancer Society, Sponsor Award ID: RSG-22-021-01-CDP
June 20, 2023 - June 19, 2026 - Profiling and Eliminating Tumor Subclones Destined for Resistance , . Sponsor: DOD Prostate Cancer Program, Sponsor Award ID: P0563731
September 15, 2018 - August 31, 2023 - Investigating How a Balance of Negative and Positive ETS Factors Controls Prostate Oncogenesis , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K08CA226348

Publications

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.

  • Publication Year
    2022
Sjöström M, Zhao SG, Levy S, Zhang M, Ning Y, Shrestha R, Lundberg A, Herberts C, Foye A, Aggarwal R, Hua JT, Li H, Bergamaschi A, Maurice-Dror C, Maheshwari A, Chen S, Ng SWS, Ye W, Petricca J, Fraser M, Chesner L, Perry MD, Moreno-Rodriguez T, Chen WS, Alumkal JJ, Chou J, Morgans AK, Beer TM, Thomas GV, Gleave M, Lloyd P, Phillips T, McCarthy E, Haffner MC, Zoubeidi A, Annala M, Reiter RE, Rettig MB, Witte ON, Fong L, Bose R, Huang FW, Luo J, Bjartell A, Lang JM, Mahajan NP, Lara PN, Evans CP, Tran PT, Posadas EM, He C, Cui XL, Huang J, Zwart W, Gilbert LA, Maher CA, Boutros PC, Chi KN, Ashworth A, Small EJ, He HH, Wyatt AW, Quigley DA, Feng FY

The DNA methylation landscape of advanced prostate cancer.

  • Publication Year
    2020
Zhao SG, Chen WS, Li H, Foye A, Zhang M, Sjöström M, Aggarwal R, Playdle D, Liao A, Alumkal JJ, Das R, Chou J, Hua JT, Barnard TJ, Bailey AM, Chow ED, Perry MD, Dang HX, Yang R, Moussavi-Baygi R, Zhang L, Alshalalfa M, Laura Chang S, Houlahan KE, Shiah YJ, Beer TM, Thomas G, Chi KN, Gleave M, Zoubeidi A, Reiter RE, Rettig MB, Witte O, Yvonne Kim M, Fong L, Spratt DE, Morgan TM, Bose R, Huang FW, Li H, Chesner L, Shenoy T, Goodarzi H, Asangani IA, Sandhu S, Lang JM, Mahajan NP, Lara PN, Evans CP, Febbo P, Batzoglou S, Knudsen KE, He HH, Huang J, Zwart W, Costello JF, Luo J, Tomlins SA, Wyatt AW, Dehm SM, Ashworth A, Gilbert LA, Boutros PC, Farh K, Chinnaiyan AM, Maher CA, Small EJ, Quigley DA, Feng FY